Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
Start Date
8/6/2021
Completion Date
9/29/2026
Summary
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
Detailed Description
PRIMARY OBJECTIVE: I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases. OUTLINE: Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
Electronic Health Record Review
Laboratory Biomarker Analysis
Conditions
Locations
M D Anderson Cancer Center
Houston, Texas 77030
United States